Hisamitsu Pharmaceutical Co Stock Five Year Return
Hisamitsu Pharmaceutical Co fundamentals help investors to digest information that contributes to Hisamitsu Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Hisamitsu Stock. The fundamental analysis module provides a way to measure Hisamitsu Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hisamitsu Pharmaceutical stock.
Hisamitsu |
Hisamitsu Pharmaceutical Co Company Five Year Return Analysis
Hisamitsu Pharmaceutical's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Current Hisamitsu Pharmaceutical Five Year Return | 1.49 % |
Most of Hisamitsu Pharmaceutical's fundamental indicators, such as Five Year Return, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hisamitsu Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
CompetitionAccording to the company disclosure, Hisamitsu Pharmaceutical Co has a Five Year Return of 1.49%. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The five year return for all Germany stocks is notably lower than that of the firm.
Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
All Next | Launch Module |
Hisamitsu Fundamentals
Return On Equity | 0.0504 | |||
Return On Asset | 0.0212 | |||
Profit Margin | 0.10 % | |||
Operating Margin | 0.09 % | |||
Current Valuation | 1.09 B | |||
Shares Outstanding | 79.53 M | |||
Shares Owned By Insiders | 26.45 % | |||
Shares Owned By Institutions | 35.29 % | |||
Price To Earning | 34.35 X | |||
Price To Book | 1.14 X | |||
Price To Sales | 0.02 X | |||
Revenue | 120.19 B | |||
Gross Profit | 70.07 B | |||
EBITDA | 17.3 B | |||
Net Income | 9.66 B | |||
Cash And Equivalents | 143.16 B | |||
Total Debt | 219 M | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 7.41 X | |||
Book Value Per Share | 3,393 X | |||
Cash Flow From Operations | 19.2 B | |||
Earnings Per Share | 0.96 X | |||
Number Of Employees | 2.78 K | |||
Beta | 0.51 | |||
Market Capitalization | 2.02 B | |||
Total Asset | 302.86 B | |||
Z Score | 5.4 | |||
Annual Yield | 0.02 % | |||
Five Year Return | 1.49 % | |||
Net Asset | 302.86 B | |||
Last Dividend Paid | 42.0 |
Currently Active Assets on Macroaxis
EBR | Centrais Electricas Brasileiras | |
HE | Hawaiian Electric Industries | |
VFC | VF Corporation | |
BVHMF | Vistry Group PLC | |
S | SentinelOne |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Tools for Hisamitsu Stock
When running Hisamitsu Pharmaceutical's price analysis, check to measure Hisamitsu Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hisamitsu Pharmaceutical is operating at the current time. Most of Hisamitsu Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Hisamitsu Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hisamitsu Pharmaceutical's price. Additionally, you may evaluate how the addition of Hisamitsu Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |